VEGFA and renal carcinoma: In the present study, we aimed to analyze whether epigenetic alterations in FLT1 and/or KDR are related to the anti-cancer effects of drugs targeting VEGF-VEGFR signaling in renal cancer cells (RCCs) and in tissues collected from renal cancer patients.